Charles River Laboratories has acquired Worcester, MA-based contract research organization (CRO) Agilux Laboratories, further bolstering the company’s early-stage services.
QPS Holdings LLC and G-CURE BV will collaborate on cardiovascular drug development programs for pharmaceutical companies.
MedPharm’s new US-based subsidiary, MP Pharma Services, has opened in Research Park Tringle to serve the growing global dermatology market.
The China Food and Drug Administration (CFDA) has withdrawn 1,184 drug registration applications following a recent yearlong government investigation into clinical trials in the country.
Bracket has randomized its first patient using Precision Block Design (PBD) technology integrated in its clinical IRT platform.
Content Provided by Reading Scientific Services Ltd.
Oral dosage forms remain one of the most flexible and effective treatments available to patients. Dissolution testing is a requirement for all solid oral dosage forms and is used throughout the development life-cycle for product release and stability testing. It is a pivotal analytical test used for detecting physical changes in an active pharmaceutical ingredient and formulated product